Horizon Therapeutics Public Ltd Co

STIFEL FINANCIAL CORP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

46,122

Value ($000)

5,336

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	5,336	0.0%	46,122	9/30/2023
2023 Q2	8/14/2023	7,352	0.0%	71,483	6/30/2023
2023 Q1	5/12/2023	8,143	0.0%	74,607	3/31/2023
2022 Q4	2/13/2023	9,919	0.0%	87,161	12/31/2022
2022 Q3	11/14/2022	5,949	0.0%	96,137	9/30/2022
2022 Q2	8/15/2022	13,393	0.0%	167,920	6/30/2022
2022 Q1	5/13/2022	11,651	0.0%	110,731	3/31/2022
2021 Q4	2/14/2022	16,556	0.0%	153,634	12/31/2021
2021 Q3	11/15/2021	16,887	0.0%	154,166	9/30/2021
2021 Q2	8/13/2021	14,346	0.0%	153,205	6/30/2021
2021 Q1	5/14/2021	15,959	0.0%	173,387	3/31/2021
2020 Q4	2/12/2021	10,112	0.0%	138,231	12/31/2020
2020 Q3	11/16/2020	6,726	0.0%	86,595	9/30/2020
2020 Q2	8/14/2020	3,154	0.0%	56,738	6/30/2020
2020 Q1	5/14/2020	2,018	0.0%	67,982	3/31/2020
2019 Q4	2/13/2020	2,967	0.0%	81,794	12/31/2019